Australia - engleză - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - pethidine hydrochloride, quantity: 50 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide - dbl pethidine hydrochloride injection is indicated for the short-term (24 to 36 hours) management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. it can be given via the following routes of administration: intramuscular, subcutaneous, slow intravenous bolus injection, intravenous infusion and patient controlled analgesia (pca).,dbl pethidine hydrochloride injection is also indicated for administration as an anaesthetic adjunct and for obstetric analgesia.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - folic acid, quantity: 5 mg/ml - injection - excipient ingredients: water for injections; sodium hydroxide; disodium edetate - 1. megaloblastic anaemia where the anaemia has been proven to be due to folate deficiency only. 2. prevention of folic acid deficiency in pregnancy and lactation.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - folic acid, quantity: 15 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; disodium edetate - 1. megaloblastic anaemia where the anaemia has been proven to be due to folate deficiency only. 2. prevention of folic acid deficiency in pregnancy and lactation.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - cyclizine lactate, quantity: 50 mg/ml - injection - excipient ingredients: lactic acid; water for injections - valoid is indicated for the prevention of nausea and vomiting in the post operative period

Australia - engleză - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - glatiramer acetate, quantity: 20 mg - injection, solution - excipient ingredients: mannitol; water for injections - copaxone is indicated for the reduction of the frequency of relapses in patients with relapsing remitting multiple sclerosis. treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent mri lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - midazolam, quantity: 1 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - intravenously as an agent for: conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy,coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid. induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be obtained with a narrower dose range and in a shorter period of time. intermittent intravenous administration or continuous infusion for: sedation in intensive care units. intramuscularly for: preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - midazolam, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - intravenously as an agent for: conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy,coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid. induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be obtained with a narrower dose range and in a shorter period of time. intermittent intravenous administration or continuous infusion for: sedation in intensive care units. intramuscularly for: preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - midazolam, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - intravenously as an agent for: conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures such as bronchoscopy, gastroscopy, cystoscopy,coronary angiography and cardiac catheterisation, either alone or in conjunction with an opioid. induction of anaesthesia preliminary to administration of other anaesthetic agents. with the use of an opioid premedicant, induction of anaesthesia can be obtained with a narrower dose range and in a shorter period of time. intermittent intravenous administration or continuous infusion for: sedation in intensive care units. intramuscularly for: preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dalteparin sodium, quantity: 10000 anti-xa iu/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - prophylaxis against thrombotic complications during haemodialysis and treatment of acute deep vein thrombosis (dvt). extended treatment of symptomatic venous thromboembolism (vte) (proximal deep vein thrombosis and/or pulmonary embolism) to reduce the recurrence of vte in patients with solid tumour cancers. treatment of unstable coronary artery disease, i.e. unstable angina and non-st-elevation myocardial infarction (also known as non-q-wave myocardial infarction). prophylaxis against thrombo-embolic complications in the peri- or postoperative period of surgery.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - naloxone hydrochloride dihydrate, quantity: 440 microgram (equivalent: naloxone hydrochloride?, qty 400 microgram) - injection - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - narcan is indicated for the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic antagonist analgesics: nalbuphine, pentazocine and butorphanol. narcan is also indicated for the diagnosis of suspected acute opioid overdosage.